Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, […]